Ipca Lab Q4 net profit up 84% at Rs 137 cr

Drug firm Ipca Laboratories today posted 84.10% jump in net profit at Rs 137.03 crore for the fourth quarter ended March 31, 2013-14.

The company had reported net profit of Rs 74.43 crore during the January-March same period of the 2012-13 fiscal.

Net sales of the company during Q4, 2013-14 were Rs 739.81 crore, up 12.32% from Rs 658.64 crore in the year-ago period, Ipca Laboratories said in a filing to the BSE.

The company's Q4 revenue from domestic formulations business stood at Rs 196.56 crore, up 10%, while the revenue from exports stood at Rs 373.18 crore, up 19%.

The Ipca Labs scrip was trading at Rs 785 on the BSE in the afternoon trade, down 0.39% from the previous close.


  • Centre and states must cooperate to get the economy moving

    Mirroring the previous three quarters, another round of tepid corporate earnings announcements are expected in a few days from now.


Stay informed on our latest news!


Sarthak Raychaudhuri

vice-president, HR, Asia South Whirlpool of India

GV Nageswara Rao

MD & CEO, IDBI Federal Life

Timothy Moe

Goldman Sachs


Arun Nigavekar

Ranking of higher education institutions

Given the massive popularity and growing influence of world university ...

Rajgopal Nidamboor

The pursuit of serene stillness

It may sound strange — that every change in the ...

Dharmendra Khandal

How positive intervention can go a long way

Ten years ago, Sariska tiger reserve declared that there were ...


William D. Green

Chairman & CEO, Accenture